Evaristo Peggion
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Evaristo Peggion has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Elisabetta Schievano
Department of Chemical Sciences, University of Padova, 35131 Padova, Italy
9 shared publications - Stefano Mammi
University of Padova
8 shared publications S. Mammi
Department of Chemistry, University of Padova, Institute of Biomolecular Chemistry, CNR, Via Marzolo 1, 35131 Padova, Italy
5 shared publicationsM. Rosenblatt
A. Barazza, A. Wittelsberger, J.M. Alexander, M. Rosenblatt and M. Chorev, Division of Bone and Mineral Research, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Ave, Boston, MA 02215, USA N. Fiori, E. Schievano, S. Mammi, C. Toniolo and E. Peggion, Department of Chemical Sciences, University of Padova, Institute of Biomolecular Chemistry, CNR, Via Marzolo 1, 35131 Padova, Italy
4 shared publicationsM. Chorev
A. Barazza, A. Wittelsberger, J.M. Alexander, M. Rosenblatt and M. Chorev, Division of Bone and Mineral Research, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Ave, Boston, MA 02215, USA N. Fiori, E. Schievano, S. Mammi, C. Toniolo and E. Peggion, Department of Chemical Sciences, University of Padova, Institute of Biomolecular Chemistry, CNR, Via Marzolo 1, 35131 Padova, Italy
3 shared publicationsMarco Tessari
Department of Organic Chemistry, University of Padova, Italy
3 shared publications
Latest Publications
- 6 July 2007
- Published by Wiley in Journal of Peptide Science
- Vol. 13 (8) , 504-512
Structure–function relationship studies of PTH(1–11) analogues containing sterically hindered dipeptide mimetics
The N-terminal 1–34 fragment of parathyroid hormone (PTH) is fully active in vitro and in vivo and reproduces all biological responses characteristic of the native intact PTH. In order to develop safer and non-parenteral PTH-like bone anabolic agents, we have studied the effect of introducing conformationally constrained dipeptide mimetics into the N-terminal portion of PTH in an effort to generate miniaturized PTH-mimetics. To this end, we have synthesized and conformationally and biologically characterized PTH(1–11) analogues containing 3R-carboxy-6S-amino-7,5-bicyclic thiazolidinlactam (7,5-bTL), a rigidified dipeptide mimetic unit. The wild type sequence of PTH(1–11) is H-Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-NH2. The following pseudo-undecapeptides were prepared: [Ala1, 7,5-bTL3, 4, Nle8, Arg11]hPTH(1–11)NH2 (I); [Ala1, 7,5-bTL6, 7, Nle8, Arg11]hPTH(1–11)NH2 (II); [Ala1, Nle8, 7,5-bTL9, 10, Arg11]hPTH(1–11)NH2 (III). In aqueous solution containing 20% TFE, only analogue I exhibited the typical CD pattern of the α-helical conformation. NMR experiments and molecular dynamics calculations located the α-helical stretch in the sequence Ile5-His9. The dipeptide mimetic unit 7,5-bTL induces a type III β-turn, occupying the positions i − 1 and i of the turn. Analogue II exhibited an equilibrium between a type I β-turn and an α-helix, and analogue III did not show any ordered structure. Biological tests revealed poor activity for all analogues (EC50 > 0.1 mM). Apparently, the relative side-chain orientation of Val2, Ile5 and Met8 can be critical for effective analogue-receptor interaction. Considering helicity as an essential property to obtain active PTH agonists, one must decorate the correctly positioned dipeptide mimetic azabicycloalkane scaffold with substitutions corresponding to the displaced amino acids. Copyright © 2007 European Peptide Society and John Wiley & Sons, Ltd.
- 6 July 2007
- Published by Wiley in Journal of Peptide Science
- Vol. 13 (8) , 504-512
Structure–function relationship studies of PTH(1–11) analogues containing sterically hindered dipeptide mimetics
The N-terminal 1–34 fragment of parathyroid hormone (PTH) is fully active in vitro and in vivo and reproduces all biological responses characteristic of the native intact PTH. In order to develop safer and non-parenteral PTH-like bone anabolic agents, we have studied the effect of introducing conformationally constrained dipeptide mimetics into the N-terminal portion of PTH in an effort to generate miniaturized PTH-mimetics. To this end, we have synthesized and conformationally and biologically characterized PTH(1–11) analogues containing 3R-carboxy-6S-amino-7,5-bicyclic thiazolidinlactam (7,5-bTL), a rigidified dipeptide mimetic unit. The wild type sequence of PTH(1–11) is H-Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-NH2. The following pseudo-undecapeptides were prepared: [Ala1, 7,5-bTL3, 4, Nle8, Arg11]hPTH(1–11)NH2 (I); [Ala1, 7,5-bTL6, 7, Nle8, Arg11]hPTH(1–11)NH2 (II); [Ala1, Nle8, 7,5-bTL9, 10, Arg11]hPTH(1–11)NH2 (III). In aqueous solution containing 20% TFE, only analogue I exhibited the typical CD pattern of the α-helical conformation. NMR experiments and molecular dynamics calculations located the α-helical stretch in the sequence Ile5-His9. The dipeptide mimetic unit 7,5-bTL induces a type III β-turn, occupying the positions i − 1 and i of the turn. Analogue II exhibited an equilibrium between a type I β-turn and an α-helix, and analogue III did not show any ordered structure. Biological tests revealed poor activity for all analogues (EC50 > 0.1 mM). Apparently, the relative side-chain orientation of Val2, Ile5 and Met8 can be critical for effective analogue-receptor interaction. Considering helicity as an essential property to obtain active PTH agonists, one must decorate the correctly positioned dipeptide mimetic azabicycloalkane scaffold with substitutions corresponding to the displaced amino acids. Copyright © 2007 European Peptide Society and John Wiley & Sons, Ltd.
- 10 March 2005
- Published by Wiley in Journal of Peptide Science
- Vol. 11 (5) , 265-267
From synthetic poly‐α‐amino acids to bioactive peptides and peptidomimetics
- 10 March 2005
- Published by Wiley in Journal of Peptide Science
- Vol. 11 (5) , 265-267
From synthetic poly‐α‐amino acids to bioactive peptides and peptidomimetics
- 4 January 2005
- Published by Wiley in Peptide Science
- Vol. 80 (2-3) , 294-302
Conformational studies of Aib‐rich peptides containing lactam‐bridged side chains: Evidence of 310‐helix formation
Aib-rich side-chain lactam-bridged oligomers Ac-( )n-Ala-OH with n = 1,2,3 were designed and synthesized as putative models of the 310-helix. The lactam bridge between the side chains of L-Glu and L-Lys in (i) − (i + 3) positions was introduced in order to enhance the structural preference toward the right-handed 310-helix. The conformational properties of the three peptides were studied in trifluoroethanol (TFE) solution by CD, NMR, and computer simulations. The structural information was derived mainly from the analysis of nuclear Overhauser effect spectroscopy spectra. The presence of αH(i)—HN(i + 2) and of αH(i)—HN(i + 3) connectivities and the absence of αH(i)—HN(i + 4) connectivities indicate that these peptides fold into a 310-helix rather than into an α-helix. Based on these conformational features, stereospecific assignment of the Aib methyl groups was possible. The results of such experiments and of the subsequent distance geometry and restrained molecular dynamics simulations reveal a marked preference of these peptides for 310-helix. The CD spectra of these peptides indicate that the helix content increases upon chain elongation. The CD spectrum of the trimer is characterized by a negative band at 200 nm and by a weak positive band around 220 nm. The CD spectrum in TFE is different from that observed in aqueous solution in the presence of SDS micelles, reported in our previous work, and from those reported by a different research group for 310-helical peptides. A possible reason for these differences could rest in the presence of different equilibria of the conformer populations of the various peptides in different solvent systems. © 2005 Wiley Periodicals, Inc. Biopolymers (Pept Sci), 2005
- 4 January 2005
- Published by Wiley in Peptide Science
- Vol. 80 (2-3) , 294-302
Conformational studies of Aib‐rich peptides containing lactam‐bridged side chains: Evidence of 310‐helix formation
Aib-rich side-chain lactam-bridged oligomers Ac-( )n-Ala-OH with n = 1,2,3 were designed and synthesized as putative models of the 310-helix. The lactam bridge between the side chains of L-Glu and L-Lys in (i) − (i + 3) positions was introduced in order to enhance the structural preference toward the right-handed 310-helix. The conformational properties of the three peptides were studied in trifluoroethanol (TFE) solution by CD, NMR, and computer simulations. The structural information was derived mainly from the analysis of nuclear Overhauser effect spectroscopy spectra. The presence of αH(i)—HN(i + 2) and of αH(i)—HN(i + 3) connectivities and the absence of αH(i)—HN(i + 4) connectivities indicate that these peptides fold into a 310-helix rather than into an α-helix. Based on these conformational features, stereospecific assignment of the Aib methyl groups was possible. The results of such experiments and of the subsequent distance geometry and restrained molecular dynamics simulations reveal a marked preference of these peptides for 310-helix. The CD spectra of these peptides indicate that the helix content increases upon chain elongation. The CD spectrum of the trimer is characterized by a negative band at 200 nm and by a weak positive band around 220 nm. The CD spectrum in TFE is different from that observed in aqueous solution in the presence of SDS micelles, reported in our previous work, and from those reported by a different research group for 310-helical peptides. A possible reason for these differences could rest in the presence of different equilibria of the conformer populations of the various peptides in different solvent systems. © 2005 Wiley Periodicals, Inc. Biopolymers (Pept Sci), 2005
- 1 January 2005
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 65 (1) , 23-35
Bioactive N‐terminal undecapeptides derived from parathyroid hormone: the role of α‐helicity*
Abstract: The N‐terminal 1–34 segment of parathyroid hormone (PTH) is fully active in vitro and in vivo and it can reproduce all biological responses in bone characteristic of the native intact PTH. Recent studies have demonstrated that N‐terminal fragments presenting the principal activating domain such as PTH(1–11) and PTH(1–14) with helicity‐enhancing substitutions yield potent analogues with PTH(1–34)‐like activity. To further investigate the role of α‐helicity on biological potency, we designed and synthesized by solid‐phase methodology the following hPTH(1–11) analogues substituted at positions 1 and/or 3 by the sterically hindered and helix‐promoting Cα‐tetrasubstituted α‐amino acids α‐amino isobutyric acid (Aib), 1‐aminocyclopentane‐1‐carboxylic acid (Ac5c) and 1‐aminocyclohexane‐1‐carboxylic acid (Ac6c): Ac5c‐V‐Aib‐E‐I‐Q‐L‐M‐H‐Q‐R‐NH2 (I); Aib‐V‐Ac5c‐E‐I‐Q‐L‐M‐H‐Q‐R‐NH2 (II); Ac6c‐V‐Aib‐E‐I‐Q‐L‐M‐H‐Q‐R‐NH2 (III); Aib‐V‐Ac6c‐E‐I‐Q‐L‐M‐H‐Q‐R‐NH2 (IV); Aib‐V‐Aib‐E‐I‐Q‐L‐M‐H‐Q‐R‐NH2 (V); S‐V‐Aib‐E‐I‐Q‐L‐M‐H‐Q‐R‐NH2 (VI), S‐V‐Ac5c‐E‐I‐Q‐L‐M‐H‐Q‐R‐NH2 (VII); Ac5c‐V‐S‐E‐I‐Q‐L‐M‐H‐Q‐R‐NH2 (VIII); Ac6c‐V‐S‐E‐I‐Q‐L‐M‐H‐Q‐R‐NH2 (IX); Ac5c‐V‐Ac5c‐E‐I‐Q‐L‐M‐H‐Q‐R‐NH2 (X); Ac6c‐V‐Ac6c‐E‐I‐Q‐L‐M‐H‐Q‐R‐NH2 (XI). All analogues were biologically evaluated and conformationally characterized in 2,2,2‐trifluoroethanol (TFE) solution by circular dichroism (CD). Analogues I–V, which cover the full range of biological activity observed in the present study, were further conformationally characterized in detail by nuclear magnetic resonance (NMR) and computer simulations studies. The results of ligand‐stimulated cAMP accumulation experiments indicated that analogues I and II are active, analogues III, VI and VII are very weakly active and analogues IV, V, VIII–XI are inactive. The most potent analogue, I exhibits biological activity 3500‐fold higher than that of the native PTH(1–11) and only 15‐fold weaker than that of the native sequence hPTH(1–34). Remarkably, the two most potent analogues, I and II, and the very weakly active analogues, VI and VII, exhibit similar helix contents. These results indicate that the presence of a stable N‐terminal helical sequence is an important but not sufficient condition for biological activity.
- 1 January 2005
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 65 (1) , 23-35
Bioactive N‐terminal undecapeptides derived from parathyroid hormone: the role of α‐helicity*
Abstract: The N‐terminal 1–34 segment of parathyroid hormone (PTH) is fully active in vitro and in vivo and it can reproduce all biological responses in bone characteristic of the native intact PTH. Recent studies have demonstrated that N‐terminal fragments presenting the principal activating domain such as PTH(1–11) and PTH(1–14) with helicity‐enhancing substitutions yield potent analogues with PTH(1–34)‐like activity. To further investigate the role of α‐helicity on biological potency, we designed and synthesized by solid‐phase methodology the following hPTH(1–11) analogues substituted at positions 1 and/or 3 by the sterically hindered and helix‐promoting Cα‐tetrasubstituted α‐amino acids α‐amino isobutyric acid (Aib), 1‐aminocyclopentane‐1‐carboxylic acid (Ac5c) and 1‐aminocyclohexane‐1‐carboxylic acid (Ac6c): Ac5c‐V‐Aib‐E‐I‐Q‐L‐M‐H‐Q‐R‐NH2 (I); Aib‐V‐Ac5c‐E‐I‐Q‐L‐M‐H‐Q‐R‐NH2 (II); Ac6c‐V‐Aib‐E‐I‐Q‐L‐M‐H‐Q‐R‐NH2 (III); Aib‐V‐Ac6c‐E‐I‐Q‐L‐M‐H‐Q‐R‐NH2 (IV); Aib‐V‐Aib‐E‐I‐Q‐L‐M‐H‐Q‐R‐NH2 (V); S‐V‐Aib‐E‐I‐Q‐L‐M‐H‐Q‐R‐NH2 (VI), S‐V‐Ac5c‐E‐I‐Q‐L‐M‐H‐Q‐R‐NH2 (VII); Ac5c‐V‐S‐E‐I‐Q‐L‐M‐H‐Q‐R‐NH2 (VIII); Ac6c‐V‐S‐E‐I‐Q‐L‐M‐H‐Q‐R‐NH2 (IX); Ac5c‐V‐Ac5c‐E‐I‐Q‐L‐M‐H‐Q‐R‐NH2 (X); Ac6c‐V‐Ac6c‐E‐I‐Q‐L‐M‐H‐Q‐R‐NH2 (XI). All analogues were biologically evaluated and conformationally characterized in 2,2,2‐trifluoroethanol (TFE) solution by circular dichroism (CD). Analogues I–V, which cover the full range of biological activity observed in the present study, were further conformationally characterized in detail by nuclear magnetic resonance (NMR) and computer simulations studies. The results of ligand‐stimulated cAMP accumulation experiments indicated that analogues I and II are active, analogues III, VI and VII are very weakly active and analogues IV, V, VIII–XI are inactive. The most potent analogue, I exhibits biological activity 3500‐fold higher than that of the native PTH(1–11) and only 15‐fold weaker than that of the native sequence hPTH(1–34). Remarkably, the two most potent analogues, I and II, and the very weakly active analogues, VI and VII, exhibit similar helix contents. These results indicate that the presence of a stable N‐terminal helical sequence is an important but not sufficient condition for biological activity.
- 1 January 2004
- Published by Wiley in Journal of Peptide Science
- Vol. 11 (1) , 3-16
Structural characterization of cyclic kallidin analogues in DMSO by nuclear magnetic resonance and molecular dynamics
The conformational properties in DMSO of two head‐to‐tail cyclic analogues of kallidin ([Lys0]‐bradykinin, KL) as well as those of the corresponding linear peptides were studied by NMR and molecular dynamics (MD) simulations. The modifications in the sequence were introduced at position 6, resulting in the four peptides, [Tyr6]‐KL (YKL), [Trp6]‐KL (WKL), cyclo‐([Tyr6]‐KL) (YCKL) and cyclo‐([Trp6]‐KL) (WCKL). The linear WKL analogue was significantly more potent than kallidin on rat duodenum preparations, whereas YKL was significantly less potent. Both cyclic peptides, YCKL and WCKL displayed similar activity, lower than that of the linear analogues and also of cyclo‐KL. The two linear analogues display high conformational flexibility in DMSO. In the predominant conformer, for both peptides, all three X‐Pro bonds adopt a trans configuration. Three out of four conformers present in YCKL and WCKL were completely assigned. The configurations at the X‐Pro bonds are the same for the two analogues. All cyclic conformers show a cis configuration in at least one X‐Pro bond and always opposite configuration for the two consecutive X‐Pro bonds. The NOE‐restrained MD calculations resulted in the detection of several elements of secondary structure in each of the conformers. Such elements are described and their possible relevance to biological activity is discussed. Copyright © 2004 European Peptide Society and John Wiley & Sons, Ltd.
- 1 January 2004
- Published by Wiley in Journal of Peptide Science
- Vol. 11 (1) , 3-16
Structural characterization of cyclic kallidin analogues in DMSO by nuclear magnetic resonance and molecular dynamics
The conformational properties in DMSO of two head‐to‐tail cyclic analogues of kallidin ([Lys0]‐bradykinin, KL) as well as those of the corresponding linear peptides were studied by NMR and molecular dynamics (MD) simulations. The modifications in the sequence were introduced at position 6, resulting in the four peptides, [Tyr6]‐KL (YKL), [Trp6]‐KL (WKL), cyclo‐([Tyr6]‐KL) (YCKL) and cyclo‐([Trp6]‐KL) (WCKL). The linear WKL analogue was significantly more potent than kallidin on rat duodenum preparations, whereas YKL was significantly less potent. Both cyclic peptides, YCKL and WCKL displayed similar activity, lower than that of the linear analogues and also of cyclo‐KL. The two linear analogues display high conformational flexibility in DMSO. In the predominant conformer, for both peptides, all three X‐Pro bonds adopt a trans configuration. Three out of four conformers present in YCKL and WCKL were completely assigned. The configurations at the X‐Pro bonds are the same for the two analogues. All cyclic conformers show a cis configuration in at least one X‐Pro bond and always opposite configuration for the two consecutive X‐Pro bonds. The NOE‐restrained MD calculations resulted in the detection of several elements of secondary structure in each of the conformers. Such elements are described and their possible relevance to biological activity is discussed. Copyright © 2004 European Peptide Society and John Wiley & Sons, Ltd.
- 24 October 2003
- Published by Wiley in Biopolymers
- Vol. 70 (4) , 534-547
Conformational and biological characterization of human parathyroid hormone hPTH(1–34) analogues containing β‐amino acid residues in positions 17–19
The N‐terminal 1–34 fragment of parathyroid hormone (PTH) elicits the full spectrum of bone‐related biological activities of the intact native sequences. It has been suggested that the structural elements essential for bioactivity are two helical segments located at the N‐terminal and C‐terminal sequences, connected by hinges or flexible points around positions 12 and 19. In order to assess the relevance of the local conformation around Gly18 upon biological function, we synthesized and characterized the following human (h) PTH(1–34) analogues containing β‐amino acid residues: equation image equation image equation image equation image equation image equation image Biological activity and binding affinity of analogue I are one order of magnitude lower than those of the parent compound. In analogue II, both binding affinity and biological activity are partially recovered. Analogues III and V have no binding affinity and very low biological activity. Both bioactivity and binding affinity are partially recovered in analogue IV. The conformational properties of the analogues in aqueous solution containing dodecylphosphocholine micelles were studied by CD, 2D‐nuclear magnetic resonance and molecular dynamics calculations. The results confirmed the presence in all analogues of two helical segments located at the N‐terminal and C‐terminal sequences. The insertion of β‐amino acid residues around position 18 does not cause appreciable conformational differences in the five analogues. The differences in biological activity and binding affinity among the five analogues cannot be related to structural differences in the membrane mimetic environment reported in this study. Our results stress the importance of the side‐chain functionalities in the sequence 17–19 for biological function. © 2003 Wiley Periodicals, Inc. Biopolymers 70: 534–547, 2003
- 24 October 2003
- Published by Wiley in Biopolymers
- Vol. 70 (4) , 534-547
Conformational and biological characterization of human parathyroid hormone hPTH(1–34) analogues containing β‐amino acid residues in positions 17–19
The N‐terminal 1–34 fragment of parathyroid hormone (PTH) elicits the full spectrum of bone‐related biological activities of the intact native sequences. It has been suggested that the structural elements essential for bioactivity are two helical segments located at the N‐terminal and C‐terminal sequences, connected by hinges or flexible points around positions 12 and 19. In order to assess the relevance of the local conformation around Gly18 upon biological function, we synthesized and characterized the following human (h) PTH(1–34) analogues containing β‐amino acid residues: equation image equation image equation image equation image equation image equation image Biological activity and binding affinity of analogue I are one order of magnitude lower than those of the parent compound. In analogue II, both binding affinity and biological activity are partially recovered. Analogues III and V have no binding affinity and very low biological activity. Both bioactivity and binding affinity are partially recovered in analogue IV. The conformational properties of the analogues in aqueous solution containing dodecylphosphocholine micelles were studied by CD, 2D‐nuclear magnetic resonance and molecular dynamics calculations. The results confirmed the presence in all analogues of two helical segments located at the N‐terminal and C‐terminal sequences. The insertion of β‐amino acid residues around position 18 does not cause appreciable conformational differences in the five analogues. The differences in biological activity and binding affinity among the five analogues cannot be related to structural differences in the membrane mimetic environment reported in this study. Our results stress the importance of the side‐chain functionalities in the sequence 17–19 for biological function. © 2003 Wiley Periodicals, Inc. Biopolymers 70: 534–547, 2003
- 1 March 2003
- Published by Wiley in Biopolymers
- Vol. 68 (3) , 437-457
Structure-function relationship studies of bovine parathyroid hormone [bPTH(1-34)] analogues containing α-amino-iso-butyric acid (Aib) residues
The N‐terminal 1–34 fragments of the parathyroid hormone (PTH) and parathyroid hormone‐related protein (PTHrP) elicit the full spectrum of bone‐related biological activities of the intact native sequences. It has been suggested that the structural elements essential for bioactivity are two helical segments located at the N‐terminal and C‐terminal sequences, connected by hinges or flexible points around positions 12 and 19. In order to assess the relevance of the local conformation around Gly12 upon biological function, we synthesized and characterized the following PTH(1–34) analogues containing Aib residues: (I) A‐V‐S‐E‐I‐Q‐F‐nL‐H‐N‐Aib‐G‐K‐H‐L‐S‐S‐nL‐E‐R‐V‐E‐Nal‐L‐R‐K‐K‐L‐Q‐D‐V‐H‐N‐Y‐NH2 {[Nle8,18, Aib11, Nal23,Tyr34]bPTH(1–34)–NH2}; (II) A‐V‐S‐E‐I‐Q‐F‐nL‐H‐N‐L‐Aib‐K‐H‐L‐S‐S‐nL‐E‐R‐V‐E‐Nal‐L‐R‐K‐K‐L‐Q‐D‐V‐H‐N‐Y‐NH2 {[Nle8,18, Aib12,Nal23,Tyr34]bPTH(1–34)–NH2}; (III) A‐V‐S‐E‐I‐Q‐F‐nL‐H‐N‐L‐G‐Aib‐H‐L‐S‐S‐nL‐E‐R‐V‐E‐Nal‐L‐R‐K‐K‐L‐Q‐D‐V‐H‐N‐Y‐NH2 {[Nle8,18, Aib13, Nal23,Tyr34]bPTH(1–34)–NH2}; (IV) A‐V‐S‐E‐I‐Q‐F‐nL‐H‐N‐Aib‐Aib‐K‐H‐L‐S‐S‐nL‐E‐R‐V‐E‐Nal‐L‐R‐K‐K‐L‐Q‐D‐V‐H‐N‐YNH2 {[Nle8,18, Aib11,12, Nal23,Tyr34]bPTH(1–34)–NH2}; (V) A‐V‐S‐E‐I‐Q‐F‐nL‐H‐N‐L‐Aib‐Aib‐H‐L‐S‐S‐nL‐E‐R‐V‐E‐Nal‐L‐R‐K‐K‐L‐Q‐D‐V‐H‐N‐Y‐NH2 {[Nle8,18, Aib12,13,Nal23,Tyr34]bPTH(1–34)–NH2}. (nL= Nle; Nal= L‐(2‐naphthyl)‐alanine; Aib= α‐amino‐isobutyric acid.) The introduction of Aib residues at position 11 in analogue I or at positions 11 and 12 in analogue IV resulted in a 5–20‐fold lower efficacy and a substantial loss of binding affinity compared to the parent compound [Nle8,18, Nal23,Tyr34]bPTH(1–34)–NH2. Both binding affinity and adenylyl cyclase stimulation activity are largely restored when the Aib residues are introduced at position 12 in analogue II, 13 in analogue III, and 12–13 in analogue V. The conformational properties of the analogues in aqueous solution containing dodecylphosphocholine micelles were studied by CD, two‐dimensional (2D) NMR and computer simulations. The results indicated the presence of two helical segments in all analogues, located at the N‐terminal and C‐terminal sequences. Insertion of Aib residues at positions 12 and 13, or of Aib dyads at positions 11–12 and 12–13, enhances the stability of the N‐terminal helix of all analogues. In all analogues the Aib residues are included in the helical segments. These results confirmed the importance of the helical structure in the N‐terminal activation domain, as well as of the presence of the Leu11 hydrophobic side chain in the native sequence, for PTH‐like bioactivity. © 2003 Wiley Periodicals, Inc. Biopolymers: 437–457, 2003
- 1 March 2003
- Published by Wiley in Biopolymers
- Vol. 68 (3) , 437-457
Structure-function relationship studies of bovine parathyroid hormone [bPTH(1-34)] analogues containing α-amino-iso-butyric acid (Aib) residues
The N‐terminal 1–34 fragments of the parathyroid hormone (PTH) and parathyroid hormone‐related protein (PTHrP) elicit the full spectrum of bone‐related biological activities of the intact native sequences. It has been suggested that the structural elements essential for bioactivity are two helical segments located at the N‐terminal and C‐terminal sequences, connected by hinges or flexible points around positions 12 and 19. In order to assess the relevance of the local conformation around Gly12 upon biological function, we synthesized and characterized the following PTH(1–34) analogues containing Aib residues: (I) A‐V‐S‐E‐I‐Q‐F‐nL‐H‐N‐Aib‐G‐K‐H‐L‐S‐S‐nL‐E‐R‐V‐E‐Nal‐L‐R‐K‐K‐L‐Q‐D‐V‐H‐N‐Y‐NH2 {[Nle8,18, Aib11, Nal23,Tyr34]bPTH(1–34)–NH2}; (II) A‐V‐S‐E‐I‐Q‐F‐nL‐H‐N‐L‐Aib‐K‐H‐L‐S‐S‐nL‐E‐R‐V‐E‐Nal‐L‐R‐K‐K‐L‐Q‐D‐V‐H‐N‐Y‐NH2 {[Nle8,18, Aib12,Nal23,Tyr34]bPTH(1–34)–NH2}; (III) A‐V‐S‐E‐I‐Q‐F‐nL‐H‐N‐L‐G‐Aib‐H‐L‐S‐S‐nL‐E‐R‐V‐E‐Nal‐L‐R‐K‐K‐L‐Q‐D‐V‐H‐N‐Y‐NH2 {[Nle8,18, Aib13, Nal23,Tyr34]bPTH(1–34)–NH2}; (IV) A‐V‐S‐E‐I‐Q‐F‐nL‐H‐N‐Aib‐Aib‐K‐H‐L‐S‐S‐nL‐E‐R‐V‐E‐Nal‐L‐R‐K‐K‐L‐Q‐D‐V‐H‐N‐YNH2 {[Nle8,18, Aib11,12, Nal23,Tyr34]bPTH(1–34)–NH2}; (V) A‐V‐S‐E‐I‐Q‐F‐nL‐H‐N‐L‐Aib‐Aib‐H‐L‐S‐S‐nL‐E‐R‐V‐E‐Nal‐L‐R‐K‐K‐L‐Q‐D‐V‐H‐N‐Y‐NH2 {[Nle8,18, Aib12,13,Nal23,Tyr34]bPTH(1–34)–NH2}. (nL= Nle; Nal= L‐(2‐naphthyl)‐alanine; Aib= α‐amino‐isobutyric acid.) The introduction of Aib residues at position 11 in analogue I or at positions 11 and 12 in analogue IV resulted in a 5–20‐fold lower efficacy and a substantial loss of binding affinity compared to the parent compound [Nle8,18, Nal23,Tyr34]bPTH(1–34)–NH2. Both binding affinity and adenylyl cyclase stimulation activity are largely restored when the Aib residues are introduced at position 12 in analogue II, 13 in analogue III, and 12–13 in analogue V. The conformational properties of the analogues in aqueous solution containing dodecylphosphocholine micelles were studied by CD, two‐dimensional (2D) NMR and computer simulations. The results indicated the presence of two helical segments in all analogues, located at the N‐terminal and C‐terminal sequences. Insertion of Aib residues at positions 12 and 13, or of Aib dyads at positions 11–12 and 12–13, enhances the stability of the N‐terminal helix of all analogues. In all analogues the Aib residues are included in the helical segments. These results confirmed the importance of the helical structure in the N‐terminal activation domain, as well as of the presence of the Leu11 hydrophobic side chain in the native sequence, for PTH‐like bioactivity. © 2003 Wiley Periodicals, Inc. Biopolymers: 437–457, 2003
- 14 August 2002
- Published by Elsevier in Biophysical Chemistry
- Vol. 101-102, 577-591
Interaction of bombolitin II with a membrane-mimetic environment: an NMR and molecular dynamics simulation approach
- 14 August 2002
- Published by Elsevier in Biophysical Chemistry
- Vol. 101-102, 577-591
Interaction of bombolitin II with a membrane-mimetic environment: an NMR and molecular dynamics simulation approach
- 1 June 2002
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 41 (25) , 8162-8175
Structure−Function Studies of Analogues of Parathyroid Hormone (PTH)-1−34 Containing β-Amino Acid Residues in Positions 11−13,
The 1−34 N-terminal fragments of human parathyroid hormone (PTH) and PTH-related protein (PTHrP) elicit the full spectrum of bone-relevant activities characteristic of the intact hormones. The structural elements believed to be required for receptor binding and biological activity are two helical segments, one N-terminal and one C-terminal, connected by hinges or flexible points located around positions 12 and 19. To test this hypothesis, we synthesized and characterized the following analogues of PTH-(1−34), each containing single or double substitutions with β-amino acid residues around the putative hinge located at position 12: I. [Nle8,18,β-Ala11,12,Nal23,Tyr34]bPTH-(1−34)NH2; II. [Nle8,18,β-Ala12,13,Nal23,Tyr34]bPTH-(1−34)NH2; III. [Nle8,18,β-Ala11,Nal23,Tyr34]bPTH-(1−34)NH2; IV. [Nle8,18,β-hLeu11,Nal23,Tyr34]bPTH-(1−34)NH2; V. [Nle8,18,β-Ala12, Nal23,Tyr34]bPTH-(1−34)NH2; VI. [Nle8,18,β-Ala13, Nal23,Tyr34]bPTH-(1−34)NH2 (β-hLeu = β-homo-leucine; β-Ala = β-alanine; Nal = l-2-naphthyl-alanine; Nle = norleucine). Analogues I and III exhibit very low binding affinity and are devoid of adenylyl cyclase activity. Analogue II, despite its very low binding capacity is an agonist. Biological activity and binding capacity are partially restored in analogue IV, and completely restored in analogues V and VI. The conformational properties of the analogues were investigated in aqueous solution containing dodecylphosphocholine (DPC) micelles as a membrane-mimetic environment using CD, 2D-NMR, and molecular dynamics calculations. All peptides fold partially into the α-helical conformation in the presence of DPC micelles, with a maximum helix content in the range of 30−35%. NMR analysis reveals the presence of two helical segments, one N-terminal and one C-terminal, as a common structural motif in all analogues. Incorporation of β-Ala dyads at positions 11,12 and 12,13 in analogues I and II, respectively, enhances the conformational disorder in this portion of the sequence but also destabilizes the N-terminal helix. This could be one of the possible reasons for the lack of biological activity in these analogues. The partial recovery of binding affinity and biological activity in analogue IV, compared to the structurally similar analogue III, is clearly the consequence of the reintroduction of Leu side-chain of the native sequence. In the fully active analogues V and VI, the helix stability at the N-terminus is further increased. Taken together, these results stress the functional importance of the conformational stability of the helical activation domain in PTH-(1−34). Contrary to expectation, insertion of a single β-amino acid residue in positions 11, 12, or 13 in analogues III−VI does not favor a disordered structure in this portion of the sequence.
- 1 June 2002
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 41 (25) , 8162-8175
Structure−Function Studies of Analogues of Parathyroid Hormone (PTH)-1−34 Containing β-Amino Acid Residues in Positions 11−13,
The 1−34 N-terminal fragments of human parathyroid hormone (PTH) and PTH-related protein (PTHrP) elicit the full spectrum of bone-relevant activities characteristic of the intact hormones. The structural elements believed to be required for receptor binding and biological activity are two helical segments, one N-terminal and one C-terminal, connected by hinges or flexible points located around positions 12 and 19. To test this hypothesis, we synthesized and characterized the following analogues of PTH-(1−34), each containing single or double substitutions with β-amino acid residues around the putative hinge located at position 12: I. [Nle8,18,β-Ala11,12,Nal23,Tyr34]bPTH-(1−34)NH2; II. [Nle8,18,β-Ala12,13,Nal23,Tyr34]bPTH-(1−34)NH2; III. [Nle8,18,β-Ala11,Nal23,Tyr34]bPTH-(1−34)NH2; IV. [Nle8,18,β-hLeu11,Nal23,Tyr34]bPTH-(1−34)NH2; V. [Nle8,18,β-Ala12, Nal23,Tyr34]bPTH-(1−34)NH2; VI. [Nle8,18,β-Ala13, Nal23,Tyr34]bPTH-(1−34)NH2 (β-hLeu = β-homo-leucine; β-Ala = β-alanine; Nal = l-2-naphthyl-alanine; Nle = norleucine). Analogues I and III exhibit very low binding affinity and are devoid of adenylyl cyclase activity. Analogue II, despite its very low binding capacity is an agonist. Biological activity and binding capacity are partially restored in analogue IV, and completely restored in analogues V and VI. The conformational properties of the analogues were investigated in aqueous solution containing dodecylphosphocholine (DPC) micelles as a membrane-mimetic environment using CD, 2D-NMR, and molecular dynamics calculations. All peptides fold partially into the α-helical conformation in the presence of DPC micelles, with a maximum helix content in the range of 30−35%. NMR analysis reveals the presence of two helical segments, one N-terminal and one C-terminal, as a common structural motif in all analogues. Incorporation of β-Ala dyads at positions 11,12 and 12,13 in analogues I and II, respectively, enhances the conformational disorder in this portion of the sequence but also destabilizes the N-terminal helix. This could be one of the possible reasons for the lack of biological activity in these analogues. The partial recovery of binding affinity and biological activity in analogue IV, compared to the structurally similar analogue III, is clearly the consequence of the reintroduction of Leu side-chain of the native sequence. In the fully active analogues V and VI, the helix stability at the N-terminus is further increased. Taken together, these results stress the functional importance of the conformational stability of the helical activation domain in PTH-(1−34). Contrary to expectation, insertion of a single β-amino acid residue in positions 11, 12, or 13 in analogues III−VI does not favor a disordered structure in this portion of the sequence.
- 1 September 1997
- Published by Wiley in Journal of Peptide Science
- Vol. 3 (5) , 336-346
Conformation of four peptides corresponding to the α-helical segments of human GM–CSF
- 1 September 1997
- Published by Wiley in Journal of Peptide Science
- Vol. 3 (5) , 336-346
Conformation of four peptides corresponding to the α-helical segments of human GM–CSF